{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:55:00Z","timestamp":1793876100915,"version":"4.7.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:sec id=\"ab-eoi250020-4\"><jats:title>Importance<\/jats:title><jats:p>Plasma cell-free DNA (cfDNA) testing is increasingly used for disease diagnosis and monitoring in retinoblastoma, with <jats:italic>RB1<\/jats:italic> allele fraction in cfDNA actively corresponding to disease status and treatment response. However, while <jats:italic>RB1<\/jats:italic> mosaicism has been reported in retinoblastoma, its clinical implications and potential impact on cfDNA testing remain unclear.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-5\"><jats:title>Objectives<\/jats:title><jats:p>To identify <jats:italic>RB1<\/jats:italic> mosaicism using paired plasma and buffy coat (containing lymphocytes, monocytes, granulocytes, and platelets) DNA testing, and to characterize the implications of <jats:italic>RB1<\/jats:italic> mosaicism on cfDNA testing outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this cross-sectional study, participants with retinoblastoma underwent testing with MSK-ACCESS (Memorial Sloan Kettering\u2013Analysis of Circulating cfDNA to Examine Somatic Status), a clinical assay that combines plasma cfDNA and buffy coat genomic DNA sequencing, enabling the detection and differentiation of somatic, heterozygous, and mosaic variants, between July 2020 and April 2024 at the Memorial Sloan Kettering Cancer Center. Mosaic findings from MSK-ACCESS were correlated with those from a subgroup of patients who concurrently underwent testing using the MSK-IMPACT germline assay. Data analysis was performed from April to September 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-7\"><jats:title>Exposure<\/jats:title><jats:p><jats:italic>RB1<\/jats:italic> mosaicism in retinoblastoma.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The <jats:italic>RB1<\/jats:italic> variant allele fractions in cfDNA and buffy coat genomic DNA were used to detect <jats:italic>RB1<\/jats:italic> mosaicism.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-9\"><jats:title>Results<\/jats:title><jats:p>A total of 136 consecutive patients with retinoblastoma (median age at diagnosis, 1.0 year [IQR, 0.4-1.7 years]; 74 [54.4%] female; 67 with bilateral disease and 69 with unilateral disease) who underwent testing with the MSK-ACCESS assay were included. <jats:italic>RB1<\/jats:italic> mosaicism was identified in buffy coat DNA from 20 patients (14.7%), with consistent results detected in all 11 participants tested concurrently by the MSK-IMPACT (Memorial Sloan Kettering\u2013Integrated Mutation Profiling of Actionable Cancer Targets) germline assay. Four participants with <jats:italic>RB1<\/jats:italic> mosaicism previously tested negative for germline <jats:italic>RB1<\/jats:italic> variants by external laboratories. Compared with heterozygous participants, participants with <jats:italic>RB1<\/jats:italic> mosaicism had a lower risk of developing bilateral disease (91.7% vs 55.0%, respectively; difference, 36.7% [95% CI, 13.8%-59.6%]; <jats:italic>P<\/jats:italic>\u2009=\u2009.002). In cfDNA, the mosaicism variant was detected both before and after treatment, with variant allele fraction initially decreasing after treatment but then stabilizing at levels consistent with mosaicism, despite the absence of clinical disease.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi250020-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The accurate detection and quantification of <jats:italic>RB1<\/jats:italic> mosaicism are crucial. <jats:italic>RB1<\/jats:italic> mosaicism should be considered when <jats:italic>RB1<\/jats:italic> variants persist in cfDNA after treatment without evidence of disease; failure to do so may lead to false-positive results and overtreatment in patients with <jats:italic>RB1<\/jats:italic> mosaicism. Identifying <jats:italic>RB1<\/jats:italic> mosaicism may improve patient counseling, inform treatment decisions, and enhance surveillance efforts.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.1079","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:01:04Z","timestamp":1746702064000},"page":"562","source":"Crossref","is-referenced-by-count":4,"title":["Detection and Characterization of <i>RB1<\/i> Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test"],"prefix":"10.1001","volume":"143","author":[{"given":"Chuan","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Robbins","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Gedvilaite","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Bowman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Vanderbilt","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rose","family":"Brannon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Fiala","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Ceyhan-Birsoy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine H.","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Ophthalmology, Weill Cornell Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge S.","family":"Reis-Filho","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Cancer Biomarker Development, Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Ophthalmology, Weill Cornell Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mandelker","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21-22","key":"eoi250020r1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cca.2010.07.032","article-title":"Cell-free DNA in the blood as a solid tumor biomarker\u2014a critical appraisal of the literature.","volume":"411","author":"Jung","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"6","key":"eoi250020r2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov"},{"key":"eoi250020r3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1479-5876-9-91","article-title":"Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage.","volume":"9","author":"Mychaleckyj","year":"2011","journal-title":"J Transl Med"},{"issue":"1","key":"eoi250020r4","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","article-title":"Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.","volume":"12","author":"Rose Brannon","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"eoi250020r5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMra1803083","article-title":"Retinoblastoma origins and destinations.","volume":"390","author":"Cobrinik","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"eoi250020r6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/humu.20940","article-title":"Detection of mosaic RB1 mutations in families with retinoblastoma.","volume":"30","author":"Rushlow","year":"2009","journal-title":"Hum Mutat"},{"issue":"17","key":"eoi250020r7","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1002\/cam4.3144","article-title":"Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: an MSKCC experience.","volume":"9","author":"Kothari","year":"2020","journal-title":"Cancer Med"},{"issue":"12","key":"eoi250020r8","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1097\/IAE.0000000000004224","article-title":"RB1 circulating tumor DNA in the blood of patients with retinoblastoma increases in untreated patients.","volume":"44","author":"Silverman","year":"2024","journal-title":"Retina"},{"issue":"3","key":"eoi250020r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100042","article-title":"RB1 circulating tumor DNA in the blood of patients with unilateral retinoblastoma: before and after intra-arterial chemotherapy.","volume":"1","author":"Francis","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"eoi250020r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100015","article-title":"Retrospective evaluation of somatic alterations in cell-free DNA from blood in retinoblastoma.","volume":"1","author":"Abramson","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"eoi250020r11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s10038-019-0696-z","article-title":"Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationships.","volume":"65","author":"Rodr\u00edguez-Mart\u00edn","year":"2020","journal-title":"J Hum Genet"},{"issue":"1","key":"eoi250020r12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","article-title":"Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.","volume":"10","author":"Cheng","year":"2017","journal-title":"BMC Med Genomics"},{"issue":"5","key":"eoi250020r13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"11","key":"eoi250020r14","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1158\/2159-8290.CD-22-0312","article-title":"Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort.","volume":"12","author":"Arora","year":"2022","journal-title":"Cancer Discov"},{"issue":"7571","key":"eoi250020r15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"9","key":"eoi250020r16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1101\/gr.094052.109","article-title":"Fast model-based estimation of ancestry in unrelated individuals.","volume":"19","author":"Alexander","year":"2009","journal-title":"Genome Res"},{"issue":"2","key":"eoi250020r17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00438-015-1130-7","article-title":"Unrevealed mosaicism in the next-generation sequencing era.","volume":"291","author":"Gajecka","year":"2016","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"eoi250020r18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13073-019-0664-4","article-title":"Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.","volume":"11","author":"He","year":"2019","journal-title":"Genome Med"},{"issue":"5","key":"eoi250020r19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrg3424","article-title":"A genomic view of mosaicism and human disease.","volume":"14","author":"Biesecker","year":"2013","journal-title":"Nat Rev Genet"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2833593\/jamaophthalmology_gao_2025_oi_250020_1751310356.58829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:00:56Z","timestamp":1752764456000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2833593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.1079","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}